Stryker Corporation (SYK)
Interest coverage
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 3,888,000 | 3,445,000 | 3,322,000 | 3,129,000 | 2,841,000 | 2,846,000 | 2,612,000 | 2,572,000 | 2,584,000 | 2,514,000 | 2,799,000 | 2,047,000 | 2,223,000 | 2,418,000 | 2,187,000 | 2,820,000 | 2,713,000 | 2,467,000 | 2,415,000 | 2,474,000 |
Interest expense (ttm) | US$ in thousands | 56,000 | 109,000 | 117,000 | 169,000 | 174,000 | 121,000 | 113,000 | 61,000 | 0 | 0 | 0 | 0 | 0 | 287,000 | 574,000 | 861,000 | 1,148,000 | 1,125,000 | 1,102,000 | 1,079,000 |
Interest coverage | 69.43 | 31.61 | 28.39 | 18.51 | 16.33 | 23.52 | 23.12 | 42.16 | — | — | — | — | — | 8.43 | 3.81 | 3.28 | 2.36 | 2.19 | 2.19 | 2.29 |
December 31, 2023 calculation
Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $3,888,000K ÷ $56,000K
= 69.43
I'm sorry, but without specific data on interest expenses and earnings before interest and taxes (EBIT) for Stryker Corp. in the given quarters, I'm unable to calculate or provide an analysis of the interest coverage ratio. This ratio is typically used to assess a company's ability to meet its interest obligations from its operating income. Please provide the necessary financial figures for a more in-depth analysis.
Peer comparison
Dec 31, 2023
Company name
Symbol
Interest coverage
Stryker Corporation
SYK
69.43
3M Company
MMM
-9.28
Artivion Inc
AORT
0.15
Baxter International Inc
BAX
6.14
Becton Dickinson and Company
BDX
4.24
Boston Scientific Corp
BSX
8.81
DexCom Inc
DXCM
36.00
Embecta Corp
EMBC
20.25
Glaukos Corp
GKOS
-8.81
Globus Medical
GMED
8.96
Haemonetics Corporation
HAE
8.46